dihydroergocristine mesylate
CHEBI:CHEBI_31490
Definition
The methanesulfonic acid salt of dihydroergocristine. It has been used as the for the symptomatic treatment of mental deterioration associated with cerebrovascular insufficiency and in peripheral vascular disease. It is also a component of ergoloid mesylate (codergocrine mesilate), a mixture of ergot alkaloid derivatives that is used as a vasodilator and has shown mild benefits in the treatment of vascular dementia.
Chemical Information
- Molecular Formula
- C36H45N5O8S
- Molecular Mass
- 707.83600
- Charge
- 0
- SMILES
- CS(O)(=O)=O.[H][C@@]12Cc3c[nH]c4cccc(c34)[C@@]1([H])C[C@H](CN2C)C(=O)N[C@@]1(O[C@]2(O)N([C@@H](Cc3ccccc3)C(=O)N3CCC[C@@]23[H])C1=O)C(C)C
- InChI
- InChI=1S/C35H41N5O5.CH4O3S/c1-20(2)34(37-31(41)23-16-25-24-11-7-12-26-30(24)22(18-36-26)17-27(25)38(3)19-23)33(43)40-28(15-21-9-5-4-6-10-21)32(42)39-14-8-13-29(39)35(40,44)45-34;1-5(2,3)4/h4-7,9-12,18,20,23,25,27-29,36,44H,8,13-17,19H2,1-3H3,(H,37,41);1H3,(H,2,3,4)/t23-,25-,27-,28+,29+,34-,35+;/m1./s1
- InChIKey
- SPXACGZWWVIDGR-SPZWACKZSA-N
Alternative Names
- (10alphaH)-5'alpha-benzyl-12'-hydroxy-3',6',18-trioxo-2'-(propan-2-yl)-9,10-dihydroergotaman methanesulfonate
- 5'alpha-Benzyl-9,10alpha-dihydro-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione monomethanesulphonate
- 9,10-dihydroergocristine mesilate
- 9,10-dihydroergocristine mesylate
- 9,10-dihydroergocristine methanesulfonate
- dihydroergocristine mesilate
- Dihydroergocristine mesylate
- dihydroergocristine methanesulfonate
- Dihydroergocristinmesilat
Treatment Applications
-
vascular dementiaView Disease →
DOID:8725
Drug Classification
-
methanesulfonate saltView Class →
CHEBI:38037
-
t178954
-
t179039
-
t180200
-
t180286
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- oboInOwl#hasDbXref
- KEGG:D07833
- core#notation
- CHEBI:31490
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- oboInOwl#hasDbXref
- KEGG:D07833
- oboInOwl#id
- CHEBI:31490
- core#notation
- CHEBI:31490
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_176497
- BFO_0000051
- http://purl.obolibrary.org/obo/CHEBI_34706
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_113357
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect16799
- owl#annotatedSource
- t180261
- owl#someValuesFrom
- t197318